STIM (NeuroStar) Company Projected Revenue
Neuronetics, Inc. (STIM) is retaining key engineers and expanding its sales agent workforce. This chart in the GURU.Markets terminal illustrates the organization's prospective sales volume, where 0.16 indicates the current level. Efficient equipment delivery supports margins; however, pressure from pharmaceuticals and complexities regarding insurance reimbursements create significant barriers to profit growth for Neuronetics, Inc. (STIM).
Analytical breakdowns and data insights for company Neuronetics Inc. (STIM)
- current price and projected stock value:
- business market valuation indicators:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Neuronetics, Inc.|STIM - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital NeuroStar|STIM - Company Total Debt|Debts to Book Capitalization Neuronetics Inc.|STIM - Company Long-Term Debts|Company Short-Term Debt Neuronetics|Quick Liquidity Indicator neurostar.com
- earnings and market ratios statistics:
STIM - Final Profit|Projected Future Earnings Neuronetics, Inc.|STIM - Market Cap to Earnings|Future Price to Earnings Neuronetics|STIM - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio Neuronetics Inc.|STIM - Operating profit EBITDA|Net earnings per share (EPS TTM) Neuronetics|STIM - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months neurostar.com|STIM - Earnings per share trend in current year|Net earnings per share growth forecast for next year Neuronetics, Inc.
- sales and revenue data:
Fundamental company analysis:Neuronetics, Inc.
Equipment and software deliveries for depression therapy from Neuronetics, Inc. (STIM) generate a steady revenue stream, which the estimated future sales metric currently prices in at 0.16. This metric reflects market expectations for operating cash flow through the discounting of prospects, where an upward trend on the chart confirms market share expansion, while a decline signals risks of overstocking and a loss of business margins.
Analysis of competing companies
Company Future Sales Volume BSX (Boston Scientific)|EW (edwards.com) - Company Future Revenue|Company Projected Revenue ResMed RMD|PODD - Company Future Sales Volume|Zimmer - Projected Sales Volume|Company Expected Sales Volume CooperSurgical|ALGN: Projected Sales Volume|Company Revenue Forecast GMED|TMDX (TransMedics Group, Inc.) - Projected Sales Volume|Alphatec Holdings (ATEC) - Company Future Sales|Projected Sales Volume AORT|Company Future Sales Volume Enovis Inc. ENOV|Projected Sales Volume IART (Integra LifeSciences)|Projected Sales Volume establishmentlabs.com ESTA|BBNX - Company Projected Revenue|IRMD: Company Projected Revenue|EMBC (Embecta Inc.) - Company Future Sales Volume|Tandem Corp - Company Future Revenue|AXGN (AxoGen, Inc.) - Projected Sales Volume|Company Expected Sales Volume si-bone.com SIBN|Company Projected Revenue Orthofix (OFIX)|Bioventus Inc (BVS) - Company Sales Forecast|OrthoPediatrics - Company Future Sales Volume|Projected Sales Volume Treace Corp TMCI|Strata Critical Medical Inc - Projected Sales Volume|Company Future Sales carlsmed.com CARL|RxSight (RXST) - Company Projected Revenue|Company Expected Revenue CLPT (ClearPoint Neuro)|Company Projected Revenue Stereotaxis Corp|Company Future Sales Volume Sight Sciences Inc (SGHT)|Projected Sales Volume OBIO|ANIK - Company Expected Sales Volume|Company Projected Revenue InspireMD NSPR|ZJYL: Company Revenue Forecast|VANI: Company Future Sales Volume|Xtant Medical Holdings - Company Projected Revenue Volume|NeuroOne Medical Technologies (NMTC) - Company Projected Revenue|Company Revenue Forecast MODD|MYO (Myomo) - Projected Sales Volume|Company Expected Sales Volume Envoy Medical Inc. COCH|Company Future Sales Volume VVOS (Vivos Therapeutics, Inc)|Projected Sales Volume enVVeno Corp (NVNO)|Company Projected Revenue Sintx Technologies, Inc. SINT|Company Future Revenue TNON|LFWD - Company Projected Revenue|Company Expected Sales Volume Autonomix Medical, Inc.|INVO Bioscience, Inc. (IVF) - Company Projected Revenue|Company Revenue Forecast BBLG|AXNX (Axonics, Inc.) - Projected Sales Volume|Company Expected Sales Volume biolase.com BIOL|Company Future Sales Volume DYNT (Dynatronics Corporation)|Company Projected Revenue Volume FNA|Projected Sales Volume INVO (INVO Bioscience)
